Thymosin Alpha-1 (5 mg Vial)

Thymosin Alpha-1 Research Information

Thymosin Alpha-1 is studied in research settings for its biological characteristics and potential applications. This information is provided for educational and research reference only.

Thymosin Alpha-1 (TA1) is a 28-amino acid peptide originally isolated from the thymus gland, recognized for its broad immunomodulatory properties. It has been investigated in different research contexts, including immune-related studies and scientific evaluations.

Research context: This educational overview presents a general research background and scientific observations.

Educational overview for research reference and general information.

Standard Research Overview

Research Information: General information related to Thymosin Alpha-1 is provided for educational and research reference only.

Week	Daily Blend (mg)	Volume (mL)
Week 1	300 mcg (0.3 mg)	18 units (0.18 mL)
Weeks 2–8	500 mcg (0.5 mg)	30 units (0.30 mL)

Research Observation: This section provides general educational and research reference information. Research studies may evaluate different parameters and observations depending on study design, methodology, and objectives.

Research Information Steps

Important: This information is for educational purposes only and is provided for general research reference only.

Concise summary of general research information.

Goal: Support understanding of immune modulation and related research concepts.
Schedule: Research observations may vary depending on study design and methodology.
Research Range: General information is provided for educational and research reference only.
Research Information: Additional scientific details may vary based on available documentation.
Storage: Follow appropriate research material handling guidelines.

Suggested approach for reviewing general research information.

Overview: Research findings may vary depending on study conditions.
Reference: Scientific information is provided for educational and research purposes.
Timeline: Research observations may differ based on available studies.
Details: Additional information can be reviewed from relevant research sources.

Proper handling helps maintain material quality.

Practical considerations for consistency and safety.

Handling: Follow appropriate research material handling guidelines.
Documentation: Maintain proper records and reference information for consistency.
Observation: Review available research information and documentation carefully.
Quality: Inspect materials according to relevant research standards.

Thymosin Alpha-1 is a naturally occurring thymic peptide that has been studied for its biological characteristics and immune-related research applications. Research has explored its role in various scientific contexts and molecular pathways.

Observations from preclinical and scientific literature.

Research Findings: Studies have explored Thymosin Alpha-1 in different research contexts.
Scientific Review: Available literature discusses various observations and research outcomes.
Research Context: Findings may vary depending on study design and available documentation.
General Note: Additional research information should be reviewed from relevant scientific sources.

Complementary strategies for general wellness and consistency.

Wellness: Maintain adequate sleep and stress management to support overall wellbeing.
Nutrition: Maintain a balanced nutrition approach as part of general wellness practices.
Activity: Engage in regular physical activity to support overall health.
Balance: Maintain healthy lifestyle habits for general wellness.

General research handling information from educational reference resources.

This content is for educational purposes only and is provided for general research reference only.

Explore related research information and background reading for BPC-157 + TB-500.

World Journal of Virology

— Dominari et al. (2020): Comprehensive review of Thymosin Alpha-1 mechanisms, research (0.8–6.4 mg SC), and clinical applications

Molecules (MDPI)

— Tao et al. (2023): Thymosin Alpha-1 in viral diseases—mechanisms and therapeutic applications in HBV, HCV, and HIV

Inflammopharmacology

— Soeroto et al. (2023): Meta-analysis of Tα1 in COVID-19; significant mortality reduction in moderate-to-critical patients

Expert Opinion on Biological Therapy

— Thymalfasin (Zadaxin) clinical overview: 1.6 mg SC twice weekly for hepatitis B treatment

Annals of the New York Academy of Sciences

— Thymosin Alpha-1: biological activities, clinical applications, and pharmacokinetics review

Clinical Immunology

— Mechanisms of thymosin alpha-1 immunomodulation: T-cell maturation and cytokine production

FDA Peptide Advisory Committee (2024)

— Safety data: Tα1 research up to 16 mg SC for 12 months showed no significant toxicity

Hospital Pharmacy

— Jordan et al. (2021): Small-volume research accuracy; recommends ≥20% syringe capacity for precision

CDC

— Vaccine administration: subcutaneous route (angle/site; no aspiration required)

Johns Hopkins Arthritis Center

— How to give a subcutaneous research: site selection, rotation, and technique

NCBI Bookshelf

— Best practices for research : asepsis, preparation, site rotation, and administration